Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Neurology|January 15, 2025
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson'sJennifer R Mammen, Aaron Lerner, Raunak Al-Rubayie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 1, 2013
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers ConsortiumMaria C Carrillo, Kaj Blennow, Holly Soares, et al.
Clinical Pharmacology and Therapeutics|January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open DataDaniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Digital Biomarkers|March 17, 2020
Metadata Concepts for Advancing the Use of Digital Health Technologies in Clinical ResearchReham Badawy, Farhan Hameed, Lauren Bataille, et al.
Clinical and Translational Science|February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseKlaus Romero, Daniela Conrado, Jackson Burton, et al.
Journal of Neurology|January 21, 2026
Three years later: tracking bothersome symptoms and impacts for people with early Parkinson's diseaseJennifer R Mammen, Varun Reddy, Aaron Lerner, et al.
Journal of Medical Internet Research|July 31, 2025
Advancing the Integration of Digital Health Technologies in the Drug Development EcosystemSakshi Sardar, Cheryl D Coon, Scottie Kern, et al.
Sensors (Basel, Switzerland)|March 26, 2022
Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson's DiseaseDerek L Hill, Diane Stephenson, Jordan Brayanov, et al.
Pageof 7